Leber’s congenital amaurosis (LCA) is a rare blinding disease with no cure. Recently, patients with LCA underwent retinal gene therapy and regained their vision to a great extent. We followed this group of LCA patients before and up to three years on an annual basis after gene therapy using fMRI to assess the feasibility and durability of retinal gene therapy over time and the role fMRI could play as an outcome measure for other future retinal interventions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords